Pomezia, Italy

Natalina Dell'Uomo



Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2003-2008

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Natalina Dell'Uomo: Innovator in Pharmaceutical Chemistry

Introduction

Natalina Dell'Uomo is a prominent inventor based in Pomezia, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating diabetes and related conditions. With a total of 3 patents, her work has garnered attention in the scientific community.

Latest Patents

Dell'Uomo's latest patents include innovative methods for utilizing α-phenylthiocarboxylic and α-phenyloxycarboxylic acids. These compounds are described for their serum-glucose-lowering and serum-lipid-lowering activities, particularly in the context of type 2 diabetes and its complications. Another notable patent involves the synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, and (R) and (S)-3,4-diaminobutanoic acid, along with their derivatives, starting from D- and L-aspartic acid.

Career Highlights

Dell'Uomo is currently associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving therapeutic options for patients suffering from metabolic disorders.

Collaborations

Throughout her career, Dell'Uomo has collaborated with esteemed colleagues, including Fabio Giannessi and Maria Ornella Tinti. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Natalina Dell'Uomo's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. Her patents reflect a dedication to addressing critical health issues, particularly in diabetes management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…